Fingerprint
Dive into the research topics of 'Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors
Yago Nieto, S. M. Tu, R. Bassett, R. B. Jones, A. M. Gulbis, N. Tannir, A. Kingham, C. Ledesma, K. Margolin, L. Holmberg, R. Champlin, L. Pagliaro
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations